Offer - Urjas Oil for just ₹ 1
Pentasa Prolonged Release Granules 2GM is a prescription medicine that is available as a Sachet. Primarily, it is used for the treatment of Ulcerative Colitis.
The correct dosage of Pentasa Prolonged Release Granules 2GM depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Pentasa Prolonged Release Granules 2GM as well, which are listed below. Such side effects of Pentasa Prolonged Release Granules 2GM normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Pentasa Prolonged Release Granules 2GM is Safe for pregnant women and Mild for women who are breastfeeding. Further, the section on Pentasa Prolonged Release Granules 2GM related warnings talks about Pentasa Prolonged Release Granules 2GM's effects on the liver, heart and kidney.
Other contraindications of Pentasa Prolonged Release Granules 2GM have been discussed in the sections ahead.
Drug reaction of Pentasa Prolonged Release Granules 2GM with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Pentasa Prolonged Release Granules 2GM is considered not safe while driving, and is not addictive.
Pentasa Prolonged Release Granules 2GM is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Pentasa Prolonged Release Granules 2GM safe for pregnant women?
Pregnant women can take Pentasa safely.
Is the use of Pentasa Prolonged Release Granules 2GM safe during breastfeeding?
Side effects of Pentasa on breastfeeding women are very mild.
What is the effect of Pentasa Prolonged Release Granules 2GM on the Kidneys?
Pentasa rarely harms the kidneys.
What is the effect of Pentasa Prolonged Release Granules 2GM on the Liver?
Very few cases of side effects of Pentasa on the liver have been reported.
What is the effect of Pentasa Prolonged Release Granules 2GM on the Heart?
Pentasa is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Pentasa Prolonged Release Granules 2GM unless your doctor advises you to do so -
Is this Pentasa Prolonged Release Granules 2GM habit forming or addictive?
No, you will not get addicted to Pentasa Prolonged Release Granules 2GM.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Pentasa Prolonged Release Granules 2GM. So it is best to avoid driving.
Is it safe?
Yes, Pentasa Prolonged Release Granules 2GM is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Pentasa Prolonged Release Granules 2GM in mental disorders is not effective.
Interaction between Food and Pentasa Prolonged Release Granules 2GM
Taking Pentasa Prolonged Release Granules 2GM with food is safe.
Interaction between Alcohol and Pentasa Prolonged Release Granules 2GM
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Pentasa Prolonged Release Granules 2GM.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asacol® (mesalamine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 684
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 820-822
